Tech Company Financing Transactions
Avant Genomics Funding Round
Avant Genomics, based in Charlottesville, secured $3 million in funding from CAV Angels, Global Impact Ventures and Halyard Partners.
Transaction Overview
Company Name
Announced On
5/13/2026
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to support continued R&D, accelerate manufacturing, and expand the team's expertise with additional hires.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
994 Research Park Blvd. 4th Floor TC4
Charlottesville, VA 22911
USA
Charlottesville, VA 22911
USA
Phone
Undisclosed
Website
Email Address
Overview
Avant Genomics is developing a first-of-its kind platform that automates liquid biopsy sample preparation for blood-based cancer detection. We are building a future where liquid biopsy isn't limited by workflow bottlenecks, making blood-based cancer detection faster, more accurate, and more accessible for labs everywhere.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Lisa Bowers
Chief Executive Officer
Rachelle Turiello
Chief Financial Officer
Daniel Goodall
Chief Marketing Officer
Kellie Hotz
Chief Operating Officer
Renna Nouwairi
VP - Bus. Development
Jay Foust
VP - Engineering
Ben Paysour
VP - Product Management
Don Arnold
Browse more venture capital transactions:
Prev: 5/13/2026: Oishii venture capital transaction
Next: 5/13/2026: Vector venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs